← Eichor
Study identifier: NCT06261658 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Improving the Quality of Cryopreserved Ovarian Tissue Reimplantation Using Platelet-enriched Autologous Plasma

Condition: Cryopreservation · Ovary Injury · Infertility, Female  ·  Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna

PhaseNA
Planned participants45
Who can joinFemale, N/A to no upper limit
Healthy volunteersNo

About this study

The study is aimed to evaluate the effects of intraovarian injection of autologous Platelet-enriched Autologous Plasma on the outcomes of orthotopic transplantation of cryopreserved ovarian tissue.

This description comes directly from the study's public registry record.

Talk to the study team

Diego Raimondo, MD  ·  0512143732  ·  die.raimondo@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Diego RaimondoBologna, BO, ItalyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06261658